AIFA places three new medicines in class pending reimbursement assessment
Italy’s medicines agency published 1 October determinations for Itvisma, Jascayd and Liraglutide Stada on 17 October. All three were placed in class C(nn), for medicines not yet assessed for reimbursement.
Event / data period: 2026-10-18
Published: · Updated:
AIFA’s three determinations dated 1 October were published in Italy’s Official Gazette on 17 October. They classify Itvisma, based on onasemnogene abeparvovec; Jascayd, containing nerandomilast; and Liraglutide Stada, containing liraglutide, as newly authorised human medicines.
The determinations took effect on 18 October. All three products were placed in class C(nn), which AIFA defines for medicines not yet assessed for reimbursement. This classification by itself is not a reimbursement decision or confirmation that sales have begun. A separate AIFA supply-regime document for its 7–11 September committee meeting lists hospital-only use for Itvisma and prescription-only supply for Liraglutide Stada.
Data
Three medicine classifications published by AIFA on 17 October
The determinations were adopted on 1 October and place each product in class C(nn), before reimbursement assessment.
| Itvisma | onasemnogene abeparvovec | C(nn) - not yet assessed for reimbursement |
| Jascayd | nerandomilast | C(nn) - not yet assessed for reimbursement |
| Liraglutide Stada | liraglutide | C(nn) - not yet assessed for reimbursement |
Methodology
Classes and active substances are taken from AIFA’s determinations. C(nn) placement does not mean reimbursement assessment is complete.
Updated:
Subjects and places
Subject proposals
- HealthSuggested
- Preserved editorial category/topic; broad candidate onlywww.gazzettaufficiale.it ↗
Geographic references
Only source-provided geographic references are shown. Opening an external map is optional. Optional story maps use OpenStreetMap. Opening a map sends your IP address and this site’s address to the map provider; location data remains readable as text without loading the map.
- Italy · Place role: Coverage · Place type: Country or area · Location precision: RegionalEvidence
- Explicit preserved editorial country/region; no city or national centroid inferredwww.gazzettaufficiale.it ↗